Financial Snapshot

Revenue
$93.14M
TTM
Gross Margin
67.56%
TTM
Net Earnings
-$168.3M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
423.9%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$48.88M
Q3 2024
Cash
Q3 2024
P/E
-1.403
Nov 13, 2024 EST
Free Cash Flow
-$133.2M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Revenue $90.12M $92.06M $101.9M $152.9M $114.6M $1.193B $307.7M $55.35M $230.8M $200.7M $148.9M $81.19M $71.48M $159.0M $71.90M $90.20M $273.0M $217.7M $126.3M $114.3M $106.3M $94.80M $77.50M $51.60M $41.40M $21.80M $16.20M $6.900M $3.400M $1.700M $700.0K $100.0K
YoY Change -2.1% -9.67% -33.36% 33.41% -90.4% 287.81% 455.9% -76.01% 14.99% 34.77% 83.42% 13.59% -55.06% 121.19% -20.29% -66.96% 25.4% 72.37% 10.5% 7.53% 12.13% 22.32% 50.19% 24.64% 89.91% 34.57% 134.78% 102.94% 100.0% 142.86% 600.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Revenue $90.12M $92.06M $101.9M $152.9M $114.6M $1.193B $307.7M $55.35M $230.8M $200.7M $148.9M $81.19M $71.48M $159.0M $71.90M $90.20M $273.0M $217.7M $126.3M $114.3M $106.3M $94.80M $77.50M $51.60M $41.40M $21.80M $16.20M $6.900M $3.400M $1.700M $700.0K $100.0K
Cost Of Revenue $33.77M $21.64M $24.90M $19.48M $21.37M $24.41M $30.55M $30.22M $34.10M $28.53M $38.51M $30.43M $21.89M $25.67M $30.90M $35.00M $147.5M $118.1M $36.00M $19.80M $14.70M $7.000M $4.200M $0.00 $0.00
Gross Profit $56.35M $70.42M $77.01M $133.4M $93.24M $1.169B $277.2M $25.14M $196.7M $172.2M $110.4M $50.76M $49.59M $133.4M $41.00M $55.10M $125.5M $99.60M $90.30M $94.50M $91.60M $87.80M $73.30M $51.60M $41.40M
Gross Profit Margin 62.53% 76.5% 75.57% 87.26% 81.35% 97.95% 90.07% 45.41% 85.23% 85.78% 74.14% 62.52% 69.37% 83.86% 57.02% 61.09% 45.97% 45.75% 71.5% 82.68% 86.17% 92.62% 94.58% 100.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Selling, General & Admin $77.42M $92.33M $122.8M $104.7M $98.70M $81.40M $52.40M $44.30M $43.30M $40.90M $40.50M $41.60M $46.80M $41.00M $41.00M $51.50M $58.90M $82.40M $43.90M $31.00M $30.00M $34.50M $18.90M $13.90M $7.900M $8.400M $6.300M $4.000M $3.200M $2.500M $900.0K $600.0K
YoY Change -16.15% -24.84% 17.33% 6.08% 21.25% 55.34% 18.28% 2.31% 5.87% 0.99% -2.64% -11.11% 14.15% 0.0% -20.39% -12.56% -28.52% 87.7% 41.61% 3.33% -13.04% 82.54% 35.97% 75.95% -5.95% 33.33% 57.5% 25.0% 28.0% 177.78% 50.0% 500.0%
% of Gross Profit 137.38% 131.12% 159.52% 78.46% 105.85% 6.96% 18.91% 176.22% 22.01% 23.76% 36.68% 81.95% 94.38% 30.74% 100.0% 93.47% 46.93% 82.73% 48.62% 32.8% 32.75% 39.29% 25.78% 26.94% 19.08%
Research & Development $114.2M $218.3M $400.3M $408.7M $434.6M $399.5M $268.5M $203.8M $182.8M $147.7M $190.0M $148.7M $126.8M $108.1M $95.10M $154.4M $153.6M $149.4M $151.7M $133.5M $122.1M $147.6M $139.7M $100.8M $64.00M $35.40M $23.60M $14.40M $9.000M $4.900M $2.800M $1.300M
YoY Change -47.71% -45.46% -2.06% -5.96% 8.77% 48.82% 31.73% 11.49% 23.74% -22.25% 27.8% 17.28% 17.31% 13.63% -38.41% 0.52% 2.81% -1.52% 13.63% 9.34% -17.28% 5.65% 38.59% 57.5% 80.79% 50.0% 63.89% 60.0% 83.67% 75.0% 115.38% 550.0%
% of Gross Profit 202.58% 310.03% 519.76% 306.27% 466.06% 34.18% 96.86% 810.7% 92.93% 85.81% 172.09% 292.88% 255.63% 81.03% 231.95% 280.22% 122.39% 150.0% 168.0% 141.27% 133.3% 168.11% 190.59% 195.35% 154.59%
Depreciation & Amortization $7.000M $12.20M $13.00M $12.50M $11.00M $8.800M $12.60M $13.20M $11.40M $11.70M $13.00M $13.80M $15.00M $16.60M $14.90M $22.50M $29.00M $33.50M $25.30M $18.00M $16.80M $17.10M $38.10M $9.300M $6.600M $3.400M $2.300M $1.100M $1.000M $500.0K $400.0K $100.0K
YoY Change -42.62% -6.15% 4.0% 13.64% 25.0% -30.16% -4.55% 15.79% -2.56% -10.0% -5.8% -8.0% -9.64% 11.41% -33.78% -22.41% -13.43% 32.41% 40.56% 7.14% -1.75% -55.12% 309.68% 40.91% 94.12% 47.83% 109.09% 10.0% 100.0% 25.0% 300.0%
% of Gross Profit 12.42% 17.32% 16.88% 9.37% 11.8% 0.75% 4.55% 52.51% 5.8% 6.8% 11.77% 27.19% 30.25% 12.45% 36.34% 40.83% 23.11% 33.63% 28.02% 19.05% 18.34% 19.48% 51.98% 18.02% 15.94%
Operating Expenses $114.2M $218.3M $400.3M $408.7M $434.6M $399.5M $268.5M $203.8M $226.0M $147.7M $190.0M $148.7M $126.8M $108.1M $136.2M $206.0M $212.5M $231.7M $199.7M $168.4M $156.3M $186.7M $183.9M $115.5M $71.90M $43.80M $30.00M $18.40M $12.30M $7.400M $3.600M $1.800M
YoY Change -47.71% -45.46% -2.06% -5.96% 8.77% 48.82% 31.73% -9.82% 52.98% -22.25% 27.8% 17.28% 17.31% -20.66% -33.88% -3.06% -8.29% 16.02% 18.59% 7.74% -16.28% 1.52% 59.22% 60.64% 64.16% 46.0% 63.04% 49.59% 66.22% 105.56% 100.0% 500.0%
Operating Profit -$263.7M -$376.2M -$446.1M -$425.1M -$440.0M $687.9M -$59.64M -$112.9M -$29.37M -$16.49M -$120.1M -$141.2M -$123.9M -$28.26M -$95.20M -$150.9M -$87.00M -$132.1M -$109.4M -$73.90M -$64.70M -$98.90M -$110.6M -$63.90M -$30.50M
YoY Change -29.9% -15.68% 4.94% -3.39% -163.96% -1253.44% -47.15% 284.24% 78.17% -86.28% -14.92% 13.93% 338.64% -70.32% -36.91% 73.45% -34.14% 20.75% 48.04% 14.22% -34.58% -10.58% 73.08% 109.51%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Interest Expense -$6.325M $0.00 $0.00 $6.851M $21.31M $21.58M $22.09M $22.47M $18.28M $17.87M $18.45M $15.49M $10.22M $11.17M -$7.600M -$2.600M $4.700M $5.300M -$2.300M -$18.80M -$13.00M -$8.700M $7.000M $9.400M $2.000M $3.600M $3.700M $1.600M $1.200M $500.0K $100.0K $100.0K
YoY Change -100.0% -67.85% -1.26% -2.28% -1.7% 22.9% 2.31% -3.16% 19.14% 51.51% -8.51% -247.03% 192.31% -155.32% -11.32% -330.43% -87.77% 44.62% 49.43% -224.29% -25.53% 370.0% -44.44% -2.7% 131.25% 33.33% 140.0% 400.0% 0.0%
% of Operating Profit 3.14%
Other Income/Expense, Net -$12.57M $11.18M -$77.18M -$18.84M -$19.00K -$5.207M -$36.43M -$39.79M -$51.30M -$37.94M -$39.64M -$30.25M -$9.023M -$8.802M $0.00 -$40.70M $0.00 $0.00
YoY Change -212.42% -114.49% 309.73% 99036.84% -99.64% -85.71% -8.44% -22.43% 35.2% -4.28% 31.04% 235.23% 2.51% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Pretax Income -$276.3M -$365.0M -$523.3M -$443.9M -$440.1M $682.7M -$96.08M -$152.6M -$80.67M -$54.43M -$161.1M -$174.3M -$135.9M -$39.32M -$102.8M -$35.10M -$31.50M -$153.9M -$185.2M -$102.0M -$65.70M -$107.5M -$250.0M -$97.40M -$38.40M -$18.40M -$10.00M -$9.900M -$7.700M -$5.300M -$2.900M -$1.700M
YoY Change -24.31% -30.25% 17.87% 0.88% -164.46% -810.61% -37.06% 89.22% 48.22% -66.21% -7.57% 28.24% 245.57% -61.75% 192.88% 11.43% -79.53% -16.9% 81.57% 55.25% -38.88% -57.0% 156.67% 153.65% 108.7% 84.0% 1.01% 28.57% 45.28% 82.76% 70.59% 466.67%
Income Tax -$200.0K $3.215M $557.0K $493.0K $613.0K $1.412M $616.0K $876.0K $506.0K -$512.0K $2.245M $406.0K $1.018M $881.0K -$300.0K -$800.0K $1.300M $800.0K -$100.0K -$200.0K $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.21%
Net Earnings -$276.1M -$368.2M -$523.8M -$444.4M -$440.7M $681.3M -$96.69M -$153.5M -$81.18M -$53.92M -$162.0M -$171.9M -$134.0M -$37.94M -$102.5M -$34.30M -$32.80M -$154.8M -$185.1M -$101.9M -$65.90M -$107.5M -$250.0M -$97.40M -$38.40M -$18.40M -$10.00M -$9.900M -$7.700M -$5.300M -$2.900M -$1.700M
YoY Change -25.03% -29.71% 17.86% 0.86% -164.68% -804.62% -37.02% 89.12% 50.56% -66.72% -5.73% 28.27% 253.15% -62.99% 198.83% 4.57% -78.81% -16.37% 81.65% 54.63% -38.7% -57.0% 156.67% 153.65% 108.7% 84.0% 1.01% 28.57% 45.28% 82.76% 70.59% 466.67%
Net Earnings / Revenue -306.31% -399.98% -514.03% -290.65% -384.47% 57.09% -31.42% -277.35% -35.17% -26.86% -108.79% -211.67% -187.43% -23.85% -142.56% -38.03% -12.01% -71.11% -146.56% -89.15% -61.99% -113.4% -322.58% -188.76% -92.75% -84.4% -61.73% -143.48% -226.47% -311.76% -414.29% -1700.0%
Basic Earnings Per Share -$1.45 -$1.97 -$2.86 -$2.49 -$2.52 $4.02 -$0.62
Diluted Earnings Per Share -$1.45 -$1.97 -$2.86 -$2.49 -$2.52 $3.78 -$0.62 -$1.100M -$612.8K -$424.7K -$1.400M -$1.497M -$1.187M -$402.8K -$1.105M -$371.2K -$356.9K -$1.724M -$2.155M -$1.298M -$1.181M -$1.944M -$4.708M -$2.319M -$1.129M -$586.0K -$362.3K -$442.0K -$390.9K -$434.4K -$226.6K -$132.8K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Cash & Short-Term Investments $303.6M $505.0M $734.0M $1.062B $1.325B $1.335B $296.1M $389.1M $308.9M $237.8M $237.0M $277.2M $241.2M $315.9M $396.2M $379.0M $482.4M $458.6M $476.2M $243.7M $286.0M $294.0M $344.4M $484.8M $138.2M $82.90M $100.2M $36.30M $19.90M $14.40M $5.500M $3.700M
YoY Change -39.88% -31.2% -30.88% -19.85% -0.79% 351.0% -23.9% 25.96% 29.9% 0.34% -14.5% 14.93% -23.65% -20.27% 4.54% -21.43% 5.19% -3.7% 95.4% -14.79% -2.72% -14.63% -28.96% 250.8% 66.71% -17.27% 176.03% 82.41% 38.19% 161.82% 48.65%
Cash & Equivalents $35.28M $88.23M $25.22M $199.0M $96.40M $194.9M $4.800M $59.60M $55.60M $12.40M $39.10M $25.40M $15.30M $17.80M $49.60M $155.6M $76.30M $63.80M $261.3M $32.10M $44.40M $34.90M $30.80M $136.0M $33.40M $24.90M $14.10M $18.60M $3.800M $10.50M $1.700M $3.700M
Short-Term Investments $268.3M $416.8M $708.7M $862.9M $1.229B $1.140B $291.4M $329.5M $253.4M $225.5M $198.0M $251.8M $225.9M $298.2M $346.6M $223.4M $406.1M $394.9M $214.9M $211.7M $241.5M $259.1M $313.5M $348.8M $104.8M $57.90M $86.10M $17.70M $16.10M $3.900M $3.800M $0.00
Other Short-Term Assets $9.779M $15.81M $23.33M $21.90M $47.20M $47.80M $14.90M $10.10M $9.800M $33.80M $5.200M $13.40M $17.90M $5.700M $6.200M $6.700M $7.100M $14.60M $12.50M $12.30M $5.800M $6.300M $8.800M $7.600M $7.400M $700.0K $800.0K $1.200M $500.0K $400.0K $100.0K $0.00
YoY Change -38.14% -32.25% 6.54% -53.6% -1.26% 220.81% 47.52% 3.06% -71.01% 550.0% -61.19% -25.14% 214.04% -8.06% -7.46% -5.63% -51.37% 16.8% 1.63% 112.07% -7.94% -28.41% 15.79% 2.7% 957.14% -12.5% -33.33% 140.0% 25.0% 300.0%
Inventory $16.10M $19.20M $15.80M $15.30M $12.70M $11.40M $10.70M $11.10M $11.30M $13.00M $13.50M $18.30M $12.70M $7.300M $6.500M $9.300M $12.20M $14.70M $18.60M $10.70M $8.600M $6.300M $3.200M
Prepaid Expenses
Receivables $1.205M $5.981M $22.49M $38.90M $36.80M $43.20M $5.000M $15.70M $19.90M $3.600M $2.200M $5.800M $4.900M $25.10M $4.800M $11.20M $21.60M $47.10M $12.50M $12.80M $6.200M $4.400M $4.500M $600.0K $1.800M $1.000M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $330.7M $546.0M $795.6M $1.138B $1.422B $1.438B $326.8M $426.0M $350.1M $288.2M $257.9M $314.6M $276.7M $354.0M $413.7M $406.2M $523.3M $535.0M $519.8M $279.5M $306.5M $311.0M $360.8M $493.0M $147.3M $84.50M $100.9M $37.50M $20.40M $14.80M $5.600M $3.800M
YoY Change -39.43% -31.37% -30.09% -19.95% -1.12% 339.93% -23.29% 21.68% 21.48% 11.75% -18.02% 13.7% -21.84% -14.43% 1.85% -22.38% -2.19% 2.92% 85.97% -8.81% -1.45% -13.8% -26.82% 234.69% 74.32% -16.25% 169.07% 83.82% 37.84% 164.29% 47.37%
Property, Plant & Equipment $36.86M $85.89M $177.5M $186.1M $199.2M $48.90M $47.50M $65.60M $71.30M $70.40M $67.00M $72.20M $78.60M $89.80M $78.30M $73.60M $114.4M $133.8M $142.1M $151.2M $149.4M $143.5M $142.4M $110.5M $63.90M $49.90M $18.70M $3.800M $2.700M $2.300M $1.400M $500.0K
YoY Change -57.08% -51.62% -4.6% -6.58% 307.36% 2.95% -27.59% -7.99% 1.28% 5.07% -7.2% -8.14% -12.47% 14.69% 6.39% -35.66% -14.5% -5.84% -6.02% 1.2% 4.11% 0.77% 28.87% 72.93% 28.06% 166.84% 392.11% 40.74% 17.39% 64.29% 180.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $25.83M $0.00 $64.83M $136.7M $279.1M $582.9M $57.10M $0.00 $0.00 $173.8M $0.00 $0.00 $8.300M $90.20M $175.0M $12.40M $0.00 $700.0K $9.100M $6.300M $0.00
YoY Change -100.0% -52.58% -51.02% -52.12% 920.84% -100.0% -100.0% -90.8% -48.46% 1311.29% -100.0% -92.31% 44.44%
Other Assets $4.644M $2.245M $2.744M $1.500M $1.000M $4.200M $1.000M $800.0K $800.0K $6.600M $33.20M $34.40M $1.000M $1.000M $7.100M $4.200M $6.300M $8.900M $14.50M $2.600M $7.400M $6.600M $9.500M $11.90M $4.200M $100.0K $100.0K $200.0K $200.0K $200.0K $100.0K $100.0K
YoY Change 106.86% -18.19% 82.93% 50.0% -76.19% 320.0% 25.0% 0.0% -87.88% -80.12% -3.49% 3340.0% 0.0% -85.92% 69.05% -33.33% -29.21% -38.62% 457.69% -64.86% 12.12% -30.53% -20.17% 183.33% 4100.0% 0.0% -50.0% 0.0% 0.0% 100.0% 0.0%
Total Long-Term Assets $67.33M $164.6M $321.6M $400.8M $555.8M $712.5M $182.1M $142.9M $148.5M $153.4M $176.6M $183.2M $329.9M $167.2M $161.8M $154.3M $201.8M $233.2M $338.8M $465.4M $310.3M $295.6M $306.4M $136.5M $79.50M $50.00M $18.90M $4.000M $2.800M $2.400M $1.600M $600.0K
YoY Change -59.1% -48.81% -19.76% -27.89% -21.99% 291.27% 27.43% -3.77% -3.19% -13.14% -3.6% -44.47% 97.31% 3.34% 4.86% -23.54% -13.46% -31.17% -27.2% 49.98% 4.97% -3.52% 124.47% 71.7% 59.0% 164.55% 372.5% 42.86% 16.67% 50.0% 166.67%
Total Assets $398.0M $710.6M $1.117B $1.539B $1.977B $2.150B $508.9M $568.9M $498.6M $441.6M $434.5M $497.8M $606.6M $521.2M $575.5M $560.5M $725.1M $768.2M $858.6M $744.9M $616.8M $606.6M $667.2M $629.5M $226.8M $134.5M $119.8M $41.50M $23.20M $17.20M $7.200M $4.400M
YoY Change
Accounts Payable $9.848M $12.98M $9.747M $22.10M $19.20M $5.900M $4.800M $2.800M $2.400M $2.700M $9.100M $2.900M $3.000M $7.200M $3.100M $13.80M $3.600M $7.200M $16.10M $7.100M $8.100M $8.700M $7.700M $6.500M $13.40M $3.700M $6.000M $1.100M $700.0K $300.0K $200.0K $0.00
YoY Change -24.13% 33.17% -55.9% 15.1% 225.42% 22.92% 71.43% 16.67% -11.11% -70.33% 213.79% -3.33% -58.33% 132.26% -77.54% 283.33% -50.0% -55.28% 126.76% -12.35% -6.9% 12.99% 18.46% -51.49% 262.16% -38.33% 445.45% 57.14% 133.33% 50.0%
Accrued Expenses $41.42M $55.22M $75.45M $93.50M $79.50M $61.80M $32.00M $35.10M $22.60M $26.80M $44.30M $41.40M $31.40M $29.90M $28.60M $39.10M $70.20M $34.80M $26.60M $17.10M $18.70M $32.00M $33.60M $17.80M $6.800M $4.700M $4.400M $2.200M $1.200M $700.0K $200.0K $300.0K
YoY Change -24.99% -26.81% -19.3% 17.61% 28.64% 93.13% -8.83% 55.31% -15.67% -39.5% 7.0% 31.85% 5.02% 4.55% -26.85% -44.3% 101.72% 30.83% 55.56% -8.56% -41.56% -4.76% 88.76% 161.76% 44.68% 6.82% 100.0% 83.33% 71.43% 250.0% -33.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $215.0M $0.00 $0.00 $0.00 $0.00 $102.7M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $0.00 $248.7M $4.800M $4.500M $2.300M $700.0K $500.0K $1.500M $1.300M $1.000M $800.0K $1.000M $0.00 $100.0K $100.0K $200.0K $200.0K $200.0K $200.0K $100.0K
YoY Change -100.0% 6.67% 228.57% 40.0% -66.67% 15.38% 30.0% 25.0% -20.0% -100.0% 0.0% -50.0% 0.0% 0.0% 0.0% 100.0%
Total Short-Term Liabilities $51.27M $68.20M $85.20M $115.8M $353.9M $82.00M $56.20M $72.20M $61.20M $64.00M $98.20M $78.50M $275.5M $64.10M $153.0M $68.40M $98.10M $165.6M $69.60M $55.70M $46.90M $63.70M $59.20M $30.20M $25.10M $12.80M $17.10M $6.200M $2.700M $1.400M $600.0K $400.0K
YoY Change -24.83% -19.95% -26.42% -67.28% 331.59% 45.91% -22.16% 17.97% -4.38% -34.83% 25.1% -71.51% 329.8% -58.1% 123.68% -30.28% -40.76% 137.93% 24.96% 18.76% -26.37% 7.6% 96.03% 20.32% 96.09% -25.15% 175.81% 129.63% 92.86% 133.33% 50.0%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $247.0M $245.2M $243.5M $242.8M $129.1M $203.0M $136.6M $14.60M $232.0M $233.8M $235.3M $336.6M $334.8M $438.1M $197.5M $391.7M $331.0M $331.1M $314.4M $113.3M $4.900M $5.100M $200.0K $400.0K $500.0K $700.0K $200.0K
YoY Change -100.0% 0.73% 0.7% 0.29% 88.07% -36.4% 48.61% 835.62% -93.71% -0.77% -0.64% -30.1% 0.54% -23.58% 121.82% -49.58% 18.34% -0.03% 5.31% 177.49% 2212.24% -3.92% 2450.0% -50.0% -20.0% -28.57% 250.0%
Other Long-Term Liabilities $215.8M $275.8M $352.5M $345.7M $218.1M $103.6M $119.7M $165.1M $188.2M $212.1M $223.2M $235.6M $118.6M $134.5M $86.40M $66.70M $75.90M $40.80M $24.00M $24.40M $14.10M $5.200M $6.700M $7.000M $1.800M $900.0K $500.0K $0.00 $0.00 $0.00 $0.00
YoY Change -21.75% -21.77% 1.96% 58.51% 110.52% -13.45% -27.5% -12.27% -11.27% -4.97% -5.26% 98.65% -11.82% 55.67% 29.54% -12.12% 86.03% 70.0% -1.64% 73.05% 171.15% -22.39% -4.29% 288.89% 100.0% 80.0%
Total Long-Term Liabilities $215.8M $275.8M $352.5M $345.7M $218.1M $350.6M $364.9M $408.6M $431.0M $341.2M $426.2M $372.2M $133.2M $366.5M $320.2M $302.0M $412.5M $375.6M $462.1M $221.9M $405.8M $336.2M $337.8M $321.4M $115.1M $5.800M $5.600M $200.0K $400.0K $500.0K $700.0K $200.0K
YoY Change -21.75% -21.77% 1.96% 58.51% -37.79% -3.92% -10.7% -5.2% 26.32% -19.94% 14.51% 179.43% -63.66% 14.46% 6.03% -26.79% 9.82% -18.72% 108.25% -45.32% 20.7% -0.47% 5.1% 179.24% 1884.48% 3.57% 2700.0% -50.0% -20.0% -28.57% 250.0%
Total Liabilities $267.0M $344.0M $437.7M $461.5M $572.0M $432.6M $421.0M $480.7M $492.2M $405.3M $524.4M $450.8M $408.7M $430.6M $473.2M $370.4M $510.7M $541.1M $531.7M $277.6M $452.6M $399.9M $396.9M $351.7M $140.2M $18.60M $22.70M $6.400M $3.100M $1.800M $1.300M $600.0K
YoY Change -22.36% -21.41% -5.16% -19.32% 32.22% 2.76% -12.42% -2.34% 21.44% -22.71% 16.33% 10.3% -5.09% -9.0% 27.75% -27.47% -5.62% 1.77% 91.53% -38.67% 13.18% 0.76% 12.85% 150.86% 653.76% -18.06% 254.69% 106.45% 72.22% 38.46% 116.67%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Basic Shares Outstanding 190.0M 187.1M shares 183.3M shares 178.6M shares 175.0M shares 169.6M shares 156.0M shares
Diluted Shares Outstanding 190.0M 187.1M shares 183.3M shares 178.6M shares 175.0M shares 180.1M shares 156.0M shares 139.6M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $236.11 Million

About Nektar Therapeutics

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. The company is headquartered in San Francisco, California and currently employs 137 full-time employees. The firm is focused on discovering and developing medicines in the field of immunotherapy. The firm has a research and development pipeline of investigational medicines in immunology and oncology. In oncology, it is focused on developing medicines based on targeting biological pathways that stimulate and sustain the body’s immune response to fight cancer. Its pipeline includes NKTR-255, Rezpegaldesleukin (REZPEG) and NKTR-0165. NKTR-255 is an investigational biologic that is designed to target the interleukin-15 (IL-15) pathway in order to activate the body’s innate and adaptive immunity. Its Rezpegaldesleukin pipeline is an investigational, potential first-in-class T regulatory cell stimulator that addresses this underlying immune system imbalance in people with many autoimmune and inflammatory conditions. Rezpegaldesleukin is being developed as a self-administered injection.

Industry: Pharmaceutical Preparations Peers: Amneal Pharmaceuticals Inc ANI Pharmaceuticals Inc BIODELIVERY SCIENCES INTERNATIONAL INC Collegium Pharmaceutical Inc DICE Therapeutics, Inc. Johnson & Johnson Phibro Animal Health Corp SIGA Technologies Inc